Can You Please Summarize It For Me SURGICAL PATHOLOGY: CONSULT
SURGICAL PATHOLOGY: CONSULT - DetailsPrinter friendly page--New window will open
About This Test
Details
Past Results
Graph of Past Results
Images
Scan on 6/21/2019 10:39 AM
Component Results
Component Your Value Standard Range
Case Report Surgical Pathology Report Case: JC19-10078
Authorizing Provider: Shahrooz Eshaghian, MD Collected: 04/25/2019
Ordering Location: Johns XXXXXXX Medical Received: 06/20/2019 1325
Laboratories
Pathologist: XXXXXXX Epstein I, MD
Specimen: Prostate:Needle Core Biopsy
GU PATHOLOGY CONSULTATION SERVICE XXXXXXX I. Epstein, M.D., Director XXXXXXX Matoso, M.D. XXXXXXX Lotan, M.D.
Diagnosis
1. Prostate (Needle Core Biopsy, SSW-19-09200, 4/25/2019):
A. Benign prostatic tissue.
B. Benign prostatic tissue.
NOTE: There are foci which may represent low-grade PIN. However, we do not diagnose low-grade PIN since its recognition is subjective and it lacks clinical relevance.
C. Benign fibromuscular tissue.
D. Prostate adenocarcinoma, XXXXXXX score 4+5=9 (Grade Group 5), involving 80% of one (1) core.
E. Prostate tissue with small focus of atypical glands, suspicious for low-grade adenocarcinoma.
F. Benign portion of seminal vesicle/ejaculatory duct.
G. Prostate adenocarcinoma, XXXXXXX score 4+5=9 (Grade Group 5), involving 50% of one (1) core.
H. Prostate adenocarcinoma, XXXXXXX score 4+5=9 (Grade Group 5), involving 70% of one (1) core. Perineural invasion identified in this case.
I. Prostatic adenocarcinoma, XXXXXXX score 4+4=8 (Grade Group 4) discontinuously involving 90% of one (1) core.
J. Benign fibromuscular tissue.
K. Prostate adenocarcinoma, XXXXXXX score 4+5=9 (Grade Group 5), involving 80% of one (1) core. Extraprostatic extension identified.
L. Benign prostatic tissue.
M-N. Benign portion of seminal vesicle/ejaculatory duct.
Grade Groups range from 1 (most favorable) to 5 (least favorable).
Pierorazio PM, Walsh PW, Partin AW, Epstein JI. Prognostic XXXXXXX grade grouping: Data based on the modified XXXXXXX scoring system. BJU Int, volume 111: pages 753-60, 2013.
Epstein JI, Zelefsky MJ, Sjoberg DD, et al. A contemporary prostate cancer grading system: A validated alternative to XXXXXXX score. Eur Urol, volume 69: pages 428-35, 2016.
The electronic signature attests that the above diagnosis is based upon the personal examination of the slides (and/or other material indicated in the diagnosis) by the responsible pathologist, and that the responsible pathologist has reviewed and approved this report.
Gross Description
Submitter: UCLA HEALTH SYSTEM (LOS ANGELES)
Received 14 slides (A1-N1) under case ID SSW-19-09200.
General Information
Collected
The report shows the presence of adenocarcinoma in prostatic core biopsy
Detailed Answer:
Hello,
Thanks for posting your query on 'Ask A Doctor' service...
The detailed report mentioned by you suggests the presence of adenocarcinoma in prostatic core biopsies.
Prostate is gland present in males at base of bladder.
There is a presence of cancer in small bits of prostatic tissue taken by the biopsy needle.
The treatment for adenocarcinoma is surgical removal of the prostate gland which may or may not is followed by chemotherapy depending on the stage of prostatic adenocarcinoma.
I suggest you consult your urologist with the report for further management.
Let me know if I can assist you further.
Thanks and take care
Dr. Shailja Puri
Surgery is mandatory in this scenario. The adenocarcinoma cannot be treated with medication.
Detailed Answer:
Hello and welcome again,
The highest XXXXXXX score is 9 which indicates that the tumor is high grade.
Surgery is essential since the tumor cannot be treated with medication alone.
Thanks and take care
Dr. Shailja Puri